VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
ASCO 2026: Kelun-Biotech / Merck TROP2 ADC Combo Reshapes First-Line NSCLC
ASCO 2026: Kelun-Biotech / Merck TROP2 ADC Combo Reshapes First-Line NSCLC
May 22, 2026 15:44 CST Updated 16:57
Share:
Kelun-Biotech
Innovative Drug Developer